Scientific Sessions 2024  /  Multi-Omics for Assessing Disease Susceptibility and Identifying Novel Mechanisms  /  Multi-Omic Integration in Human Cardiovascular Disease: From Molecules to Mechanism
Logo

American Heart Association

  105
  0

Final ID:

Multi-Omic Integration in Human Cardiovascular Disease: From Molecules to Mechanism

  • Shah, Ravi  ( VUMC , Nashville , Tennessee , United States )
  • Lindholm, Malene  ( Stanford University , Stanford , California , United States )
  • Katz, Daniel  ( Stanford University , Mountain View , California , United States )
    • Author Disclosures:
    Ravi Shah: DO have relevant financial relationships ; Consultant:cytokinetics:Past (completed) ; Individual Stocks/Stock Options:Thryv Therapeutics:Active (exists now) ; Consultant:amgen:Past (completed) | Malene Lindholm: DO NOT have relevant financial relationships | Daniel Katz: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Multi-Omics for Assessing Disease Susceptibility and Identifying Novel Mechanisms

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Multi-Omics for Disentangling Clinical Heterogeneity: Heart Failure as a Paradigm

Ho Jennifer, Shah Sanjiv, Shah Svati

Platform Compatibility and Meta-analysis Approaches for High-Throughput Omics Platforms: The TOPMed Experience

Yu Bing, Raffield Laura, Feofanova Elena

More abstracts from these authors:
Integrative analysis of MoTrPAC and LINCS transcriptomes identifies cardiovascular-relevant exercise-mimetic drugs

Brochet Pauline, Jimenez-morales David, Lindholm Malene, Wheeler Matthew, Katz Daniel

CMD biomarkers across the spectrum of ageing and CV risk: traditional and “multi-ome” across age

Shah Ravi

You have to be authorized to contact abstract author. Please, Login
Not Available